$0.92 Earnings Per Share Expected for Integer Holdings Corp (ITGR) This Quarter
Equities analysts expect Integer Holdings Corp (NYSE:ITGR) to post earnings per share (EPS) of $0.92 for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Integer’s earnings. The lowest EPS estimate is $0.86 and the highest is $0.97. Integer posted earnings of $0.82 per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 12.2%. The company is scheduled to report its next quarterly earnings results on Thursday, October 25th.
On average, analysts expect that Integer will report full-year earnings of $3.57 per share for the current fiscal year, with EPS estimates ranging from $3.56 to $3.57. For the next fiscal year, analysts anticipate that the firm will report earnings of $4.02 per share, with EPS estimates ranging from $3.98 to $4.06. Zacks Investment Research’s EPS averages are a mean average based on a survey of analysts that that provide coverage for Integer.
Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, August 2nd. The medical equipment provider reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.88 by $0.18. Integer had a return on equity of 12.60% and a net margin of 6.63%. The business had revenue of $313.00 million during the quarter, compared to analysts’ expectations of $379.41 million. During the same period in the previous year, the firm earned $0.62 earnings per share. The firm’s quarterly revenue was up 11.4% compared to the same quarter last year.
Shares of Integer stock opened at $71.45 on Tuesday. The company has a quick ratio of 2.95, a current ratio of 3.80 and a debt-to-equity ratio of 1.64. Integer has a 12 month low of $42.50 and a 12 month high of $76.85. The firm has a market cap of $2.26 billion, a P/E ratio of 25.43, a P/E/G ratio of 1.32 and a beta of 0.86.
In other Integer news, CFO Jeremy Friedman sold 6,326 shares of the business’s stock in a transaction dated Monday, August 6th. The stock was sold at an average price of $72.01, for a total value of $455,535.26. Following the completion of the transaction, the chief financial officer now directly owns 8,366 shares of the company’s stock, valued at $602,435.66. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 3.60% of the stock is currently owned by insiders.
A number of large investors have recently bought and sold shares of ITGR. American Century Companies Inc. lifted its holdings in shares of Integer by 97.4% in the first quarter. American Century Companies Inc. now owns 141,694 shares of the medical equipment provider’s stock valued at $8,013,000 after purchasing an additional 69,910 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of Integer by 0.5% in the first quarter. JPMorgan Chase & Co. now owns 833,032 shares of the medical equipment provider’s stock valued at $47,107,000 after purchasing an additional 4,143 shares in the last quarter. Algert Global LLC lifted its holdings in shares of Integer by 42.8% in the first quarter. Algert Global LLC now owns 77,892 shares of the medical equipment provider’s stock valued at $4,405,000 after purchasing an additional 23,359 shares in the last quarter. Prudential Financial Inc. lifted its holdings in shares of Integer by 188.9% in the first quarter. Prudential Financial Inc. now owns 175,203 shares of the medical equipment provider’s stock valued at $9,907,000 after purchasing an additional 114,549 shares in the last quarter. Finally, Campbell & CO Investment Adviser LLC bought a new stake in shares of Integer in the first quarter valued at about $373,000. 96.67% of the stock is owned by hedge funds and other institutional investors.
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products.
Featured Article: Earnings Per Share
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.